Effectiveness of Non-invasive Vagus Nerve Stimulation as an Adjuvant Treatment in Patients With Sepsis in Intensive Care.

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 29, 2021

Primary Completion Date

March 29, 2025

Study Completion Date

March 29, 2025

Conditions
SepsisSeptic Shock
Interventions
OTHER

SNV activ group (Non-invasive transcutaneous stimulation of the vagus nerve )

A transcutaneous stimulator of the atrial branch of the vagus nerve of the TENS eco Plus type (Schwa-medico) will be used. SNV stimulation will be applied in the concha of the left ear to the subcutaneous area of the atrial branch of the vagus nerve in the left ear (cymba conchae) for each patient, at an intensity of 2 mA, 30 minutes per day for 5 consecutive days, from the day of inclusion / randomization.

OTHER

Placebo group

For the control group, the stimulation electrode will be inverted so as to deliver the stimulation to the ear lobule.

Trial Locations (1)

Unknown

RECRUITING

Raymond Poincaré Hospital, Garches

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER